peter attia on semaglutide 320 – AMA 64: New insights GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape Cause for caution with weight

By targeting appetite and metabolism, these injections offer a powerful tool for sustainable weight management under expert guidance

Because your body: Never fully adapts Stays in a constant adjustment phase Experiences prolonged low-level discomfort (like nausea) Instead of short adaptation you get drawn-out inefficiency

IV Therapy Hydrate

When you go off the drugs and then take them again, youre more likely to experience the gastrointestinal side effects again, she says, noting that these tend to lessen as you get used to the medication

Real life

Common experiences during the first few weeks: Increased appetite compared to your experience on Mounjaro